Capturing the young child's reports of cancer treatment tolerability: Does our practice reflect an assumption that they cannot report?

Affiliations

• ¹ Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
• ² Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
• ³ Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA.
• ⁴ Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California, USA.
• ⁵ College of Nursing, University of Utah, Center for Cancer & Blood Disorders, Primary Children's Hospital, Salt Lake City, Utah, USA.
• ⁶ Division of Pediatric Hematology/Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
• ⁷ Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
• ⁸ Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
• ⁹ Division of Quality of Life and Palliative Care, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
• ¹⁰ Population Sciences and Pediatric Hematology/Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts, USA.
• ¹¹ Division of Oncology, Children's National Hospital, Washington, District of Columbia, USA.
• ¹² Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
• ¹³ Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
• ¹⁴ Department of Nursing Science, Professional Practice & Quality, Children's National Hospital, Washington, District of Columbia, USA.
• ¹⁵ School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia, USA.